Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 15, 2021

Long-Term Survival in Early-Stage NSCLC Treated With Stereotactic Ablative Radiotherapy

Clinical Oncology


Additional Info

Clinical Oncology
Long-Term Overall Survival Outcomes in Patients With Early Stage, Peripherally Located, Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy in a Non-Academic Cancer Centre
Clin Oncol (R Coll Radiol) 2021 May 01;33(5)283-291, A Wood, E Aynsley, G Kumar, S Masinghe, M Anderson, J Veeratterapillay, C Huntley, A Blower, J Green, D Johnson, J Daniel, H Curtis, J Reynolds, M Turnbull, K Harland, A Swingler, E Banham, K Burke, J Bradley, A Greenhalgh, C Peedell

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading